Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study | Researchclopedia
Back to research
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
2016
492 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
35.91
·
Istituti di Ricovero e Cura a Carattere Scientifico
Guy Kantor
·
Institut Bergonié
Martin Klein
·
Leiden University
Mohamed Ben Hassel
·
Centre Eugène Marquis
Christian Hartmann
·
German Cancer Research Center
Gail Ryan
·
Peter MacCallum Cancer Centre
David Capper
·
German Cancer Research Center
Johan M. Kros
·
Erasmus MC Cancer Institute
Sebastian Kurscheid
·
University of Lausanne
Wolfgang Wick
·
German Cancer Research Center
Roelien H. Enting
·
University of Groningen
Michele Reni
·
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
Brian Thiessen
·
BC Cancer Agency
F. Dhermain
·
Institut Gustave Roussy
Jacoline E. C. Bromberg
·
Erasmus MC Cancer Institute
L. Feuvret
·
Assistance Publique – Hôpitaux de Paris
Jaap C. Reijneveld
·
Amsterdam UMC Location VUmc
Olivier Chinot
·
Aix-Marseille Université
Johanna M. M. Gijtenbeek
·
Radboud University Medical Center
John P. Rossiter
·
Queen's University
Nicolas Dif
·
European Organisation for Research and Treatment of Cancer
Carmen Balañá
·
Hospital Universitari Germans Trias i Pujol
Jose Bravo-Marques
·
IPO Porto
Paul M. Clément
·
KU Leuven
Christine Marosi
·
Medical University of Vienna
Tzahala Tzuk-Shina
·
Rambam Health Care Campus
Robert Nordal
·
University of Calgary
Jeremy Rees
·
National Hospital for Neurology and Neurosurgery
Denis Lacombe
·
European Organisation for Research and Treatment of Cancer
Warren Mason
·
Princess Margaret Cancer Centre
Roger Stupp
·
University of Lausanne